
Saturday, August 24, 2024 4:48:39 PM
Pliss, and your 699 P’s ?
What about them? Does that mean it's an absolute that were going to receive a recovery? The answer is no, it's not an absolute.
Has there been anyone in an authoritative position, who would be 'in the know' about any possible recovery to us, that has stated that we will definitely receive a recovery? The answer is no, again. In fact, those in an authoritative position have said the opposite.
The bankruptcy case closed +4 1/2 years ago. The WMI Liquidating Trust (WMILT) was dissolved +2 1/2 years ago. There has been nothing. Even CSNY's supposed Source's information has resulted in a big nothing. For a long time i’ve strongly believed that CSNY has never had direct contact with the Source and either the Source had given fabricated information, passed on to her by the “another legacy holder” or the “another legacy holder” had fabricated the Source story to her. However, her unwillingness to reach out to the source for an update, when multiple people have asked over the years, and especially her stating that the source is “unimportant” to her (stated 4 months ago) leads me to a possible alternative belief.
I acknowledge that LIBOR is still ongoing and the Receivership is still open. And, i already gave you my beliefs on them at BP.
Recent COOP News
- Mr. Cooper Group Inc. to Release Second Quarter 2025 Financial Results on July 23, 2025 • Business Wire • 07/09/2025 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:08:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2025 08:04:34 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/09/2025 01:02:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 01:00:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 08:04:40 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/09/2025 09:27:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:05:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2025 08:18:01 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/23/2025 09:14:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/23/2025 08:27:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 11:00:51 AM
- Mr. Cooper Group Reports First Quarter 2025 Results • Business Wire • 04/23/2025 11:00:00 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/10/2025 08:06:09 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 11:10:10 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2025 11:05:11 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 11:00:25 AM
- Mr. Cooper Group Inc. to Release First Quarter 2025 Financial Results on April 23, 2025 • Business Wire • 04/09/2025 11:53:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2025 09:03:34 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/09/2025 09:01:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/04/2025 09:16:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2025 08:20:43 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/01/2025 08:45:12 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/01/2025 08:42:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2025 08:35:29 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM